Predict your next investment

Corporation
MOBILE & TELECOMMUNICATIONS | Mobile Software & Services / Social
blued.cn

See what CB Insights has to offer

Founded Year

2000

Stage

IPO | IPO

Total Raised

$132.09M

Date of IPO

7/8/2020

About Blued

Blued (NASDAQ: BLCT), developed by BlueCity, is a China-based mobile social dating app for gay men.

Blued Headquarter Location

Block B, Building 2, North District of Apple Community Baiziwan Road, Chaoyang District

Beijing, Beijing, 100000,

China

+86 400-898-9588

Latest Blued News

Blued Expands Access to HIV Services with Innovative Digital Prevention Feature

Nov 30, 2021

11/30/2021 | 07:31am EST Message : *Required fields BEIJING, Nov. 30, 2021 /PRNewswire/ -- BlueCity (Nasdaq: BLCT), a world-leading LGBTQ platform that fosters connection and well-being, is integrating HIV prevention organizations into the international edition of its social networking app, Blued, as part of a landmark new feature ahead of World AIDS Day (Dec. 1, 2021). Set to be officially launched by the end of the year, Blued's digital HIV prevention feature will be amplified with BlueCity's #BePositive campaign in several markets around the world. The launch will be followed by a joint report with UNAIDS on digitally-enabled HIV prevention in China. "BlueCity has channeled significant efforts into building up our HIV awareness and prevention capabilities," said Baoli Ma, founder, chairman and CEO of BlueCity. "By educating our global community, we hope to empower them with the knowledge and resources necessary to protect themselves and their loved ones. These initiatives have the power to change—and even save—lives." BlueCity pioneered the concept of digitally-enabled HIV prevention in 2008, by integrating online and offline resources to streamline access to HIV testing, counseling and treatment. Earlier this year, BlueCity began inviting organizations to register on Blued and provide critical HIV-related services to the app's 6+ million monthly active users in 170 countries and regions around the world. Organizations that are verified by Blued will receive in-app and social media support to provide their services within their region, boosting their visibility as well as awareness of preventative action. Users can directly contact these organizations to receive counseling, book appointments for HIV testing, access to PrEP and PEP and home kit deliveries, and more. Moreover, Blued will co-host HIV awareness sessions with these organizations via the app's livestream feature. Interested organizations are welcome to apply to participate by filling out the form here . In China, Blued has amassed a network comprising nearly 7,000 testing locations across the country. Blued users can easily find the resources in the app, and even make appointments directly with testing centers in over 30 Chinese cities, providing them with discrete, stress-free services during times of concern for their health. To amplify this initiative, Blued will launch a dedicated campaign with the hashtag #BePositive on its app and social media platforms in South Korea, Japan, Vietnam, India, the Philippines, Brazil and Mexico, to promote protected sex and regular HIV testing. Already, Blued has partnered with local governments and health institutions in markets, such as Brazil, India, Indonesia, Japan, Mexico, South Korea, Thailand and Vietnam to facilitate HIV testing, prevention and education. Providing direct access to health services represents the next chapter in Blued's commitment to tackle HIV/AIDS. In China, BlueCity will release a joint report with UNAIDS on digitally enabled HIV intervention. 2021 also marks the 9th consecutive year of An AIDS-Free Generation, a program spearheaded by BlueCity and the China Foundation for the Prevention of STD/AIDS (CFPSA), which provides support to HIV prevention initiatives in local communities. One such example is the Danlan Public Interest Fund, which received a grant from BlueCity in August 2019 to strengthen HIV prevention efforts among China's youth and vulnerable populations. BlueCity has long worked with partners across government, academia and industry to conduct research on HIV. Since 2016, BlueCity has co-published 22 research papers in renowned academic journals, including the Lancet Infectious Diseases. They seek to provide evidence-based suggestions for the implementation of HIV prevention initiatives around the world. About BlueCity BlueCity (NASDAQ: BLCT) is a world-leading online LGBTQ community providing a comprehensive suite of services to foster connections and enhance the wellbeing of the global LGBTQ community. The company fulfills both the daily and lifelong needs of its members through a wide range of targeted and tailored services, including social networking, livestreaming and health-related services. With commitment to providing high-quality user experience, ensuring privacy protection, and promoting community health and well-being, BlueCity has captured the hearts and minds of LGBTQ people across the globe. Available in 13 languages, BlueCity's mobile app Blued has connected more than 60 million registered users in about 170 countries and regions. According to Frost and Sullivan 2020, it is the largest online LGBTQ community in China, India, South Korea, Thailand and Vietnam by MAUs. Media Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Blued

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Blued in 1 CB Insights research brief, most recently on Feb 12, 2020.

Blued Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Blued Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.